Green Cross Flu Vaccine 'GC Flu' Secures 13 Billion Won Order for Thailand Shipment

GC Green Cross announced on the 23rd that its influenza vaccine ‘GCFLU’ has secured an order worth approximately 10 million USD (about 13 billion KRW) in next year’s bidding from Thailand’s state-owned pharmaceutical company, GPO (Government Pharmaceutical Organization).

GC Green Cross's influenza vaccine 'GC Flu'
Photo by GC Green Cross

This contract represents the largest scale since GC Green Cross entered the Thai influenza vaccine market in 2014. The company explained, "Contract terms such as the amount and duration may change later based on agreements with the counterpart country."

Lee Woo-jin, Head of Global Business Division at GC Green Cross, stated, “Since the seasonal influenza vaccine has a fixed vaccination period before the outbreak, rapid response capability is a crucial factor in securing export contracts. The government’s support for vaccine exports and the shortening of national batch release approval schedules provided significant administrative assistance in concluding this contract.” He added, “Based on the position we have built in the international organization procurement market, we plan to accelerate entry into private markets in individual countries.”

GC Green Cross is the largest manufacturer supplying seasonal influenza vaccines to international organizations under the WHO, providing influenza vaccines to 63 countries worldwide. To date, it has produced over 300 million doses, solidifying its reputation as a leading vaccine company.

This content was produced with the assistance of AI translation services.